Suchergebnisse - (Subject:"Ritonavir")

PubPharm (2.062)

51

Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levels

enthalten in: Scientific reports | 2022

von Arabi, Y. | Asiri, A. | Assiri, A. | +21

52

Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Xu, H. | Liu, G. | Gong, J. | +11

53

Quality of hospital emergency department care for patients with COVID-19 during the first wave in 2020 : the CALUR-COVID-19 study

enthalten in: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias | 2022

von Jiménez, S. | Miró, �. | Alquézar-Arbé, A. | +8

54

Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Copertino, D. | Casado Lima, B. | Duarte, R. | +6

55

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment

enthalten in: Journal of pharmaceutical sciences | 2022

von Sahin, G. | Akbal-Dagistan, O. | Culha, M. | +4

56

Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients : An updated network meta-analysis of 48 randomized controlled trials

enthalten in: Medicine | 2022

von Cheng, Q. | Zhao, G. | Chen, J. | +2

57

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques

enthalten in: International journal of molecular sciences | 2022

von Okafor, S. | Angsantikul, P. | Ahmed, H.

58

COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy

enthalten in: The Journal of infection | 2022

von Coulson, J. | Adams, A. | Gray, L. | +1

CommentIn: J Infect. 2022 Nov;85(5):e134-e136. - PMID 35995309

59

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE) : A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

enthalten in: PLoS medicine | 2022

von Lowe, D. | Brown, L. | Chowdhury, K. | +15

60

A systematic review and Bayesian network meta-analysis for comparative safety assessment of favipiravir interventions in hospitalized COVID-19 patients

enthalten in: Journal of infection in developing countries | 2022

von Yang, K. | Zeng, J. | Dai, W. | +2